Model N

Photo: Zalasem1 / Wikimedia Commons, CC BY 4.0

Model N acquires Kalderos to add claims-level 340B drug discount data

Model N's own research found that only 1% of life sciences revenue leaders had real-time visibility into 340B discounts and government rebates; buying Kalderos gives it claims-level data across those programs.